×

Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

Prostate Cancer Awareness Month

The Prostate Cancer Foundation Launches PSA Starring Actor Dax Shepard and First-Ever PCF Pushup Challenge as Part of Its ‘Do Blue’ Campaign to Kick-off Prostate Cancer Awareness Month

LOS ANGELES, Calif., September 4, 2018 – This year marks the 25th anniversary of the Prostate Cancer Foundation’s (PCF) efforts of advancing prostate cancer research. In honor of Prostate Cancer...Read More

Immunotherapy could offer hope for some men with aggressive prostate cancers

Immunotherapy could offer hope for some men with aggressive prostate cancers

Original Press Release issued by: The Institute of Cancer Research, London Study finds that a subset of men with prostate cancer have ‘mismatch’ DNA repair defects in their tumours These men...Read More

2018_YIAwardsAnnounce_FeaturedImg745x510(sg_01)

The Prostate Cancer Foundation Announces Recipients of the 2018 PCF Young Investigator Awards

LOS ANGELES, Calif., August 28, 2018 – The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated...Read More

2018_MovemberChallengeAwdsAnnounce_FeaturedImg745x510(sg_01)

The Prostate Cancer Foundation and the Movember Foundation Announce 2018 Challenge Awards Winners

SANTA MONICA, Calif., August 16, 2018 – The Prostate Cancer Foundation (PCF) and the Movember Foundation today announced four new Movember Foundation-PCF Challenge Award teams at some of the world’s leading academic research...Read More

ChristineJones_FeaturedImg745x510(sg_01)

The Prostate Cancer Foundation Appoints Christine Jones as Chief Operating Officer

SANTA MONICA, Calif., August 1, 2018 – The Prostate Cancer Foundation (PCF) today announced that Christine Jones has been appointed Chief Operating Officer effective immediately reporting to Jonathan W. Simons,...Read More

FengUCSF_CellPaper_FeaturedImg745x510(sg_01)

Genomic Landscape of Metastatic Prostate Cancer Unveiled in New Study

A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form...Read More

RESPOND_Study_FeaturedImg745x510(sg_02)

NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men

The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun. The $26.5 million study is called RESPOND, or Research...Read More

07-13_BreakingNews_FeaturedImg745x510

FDA Approves Enzalutamide (Xtandi) for Non-Metastatic Castration-Resistant Prostate Cancer

July 13, 2018 – Today the U.S. Food and Drug Administration (FDA) approved enzalutamide (Xtandi) for the treatment of non-metastatic castration-resistant prostate cancer (non-metastatic CRPC).  Non-metastatic CRPC is a clinical...Read More

Deadly Form of Advanced Prostate Cancer is Common, Calls for Distinct Treatment

Deadly Form of Advanced Prostate Cancer is Common, Calls for Distinct Treatment

Original article issued by UCSF News. A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large...Read More

Cancer Cells

Tumors Grown in the Lab Provide Insights on Rare Prostate Cancer

Original article issued by Weill Cornell Medicine. Growing miniature tumors from patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer,...Read More